Robert Goulet

15.6K posts

Robert Goulet banner
Robert Goulet

Robert Goulet

@Dadbod4evah

biotech investor...focused on undervalued stocks w/opportunity to pop. Lover of fine French wine🍾🍷 Drawing above was done by my brilliant son when he was 11❤️

bore'lando fl. Katılım Nisan 2012
647 Takip Edilen1.2K Takipçiler
Robert Goulet
Robert Goulet@Dadbod4evah·
@BiotechXGuru I'm sure Trump will probably find away to ruin tomorrow with some Iran bullshit
English
0
1
2
88
TaraBull
TaraBull@TaraBull·
Why do people that get beat up, still keep trying to fight?
English
359
82
1.2K
67.9K
Food Pleaser
Food Pleaser@FoodPleaser·
Boiled Chicken, White Rice, Plain Greek Yogurt. What’s missing here? 🍗 🍚
Food Pleaser tweet media
English
2.6K
44
641
153.4K
Steve Mano 🇬🇧 🇨🇦
Yeah the share awards are the issuance of new shares but I am talking about the buybacks the company has been doing including 250k shares or so in Q1 of this year. Of course, perfectly legal but just surprised that it is when the company knows what the results of the ongoing trial are and the people that they are buying back shares from do not. Just philosophical musings (ignore me)
English
1
0
1
151
Steve Mano 🇬🇧 🇨🇦
$ALLR I just voted "for" each of the management proposals ahead of the annual meeting. Nothing to overthink here - current management is the REASON this company is turning around so not trust them doesn't make sense to me. Even regarding dilution, management has far more insight into the current state of play than us, and if they deem it necessary (in line with all other biotech nanocaps), then I trust them.
English
4
0
9
971
Robert Goulet
Robert Goulet@Dadbod4evah·
$KYTX a reminder Affiliated insider purchase: Westlake Village BioPartners (major backer) bought 133,333 shares at $7.50 in Dec 25. Bullish
English
0
0
1
159
Steve Mano 🇬🇧 🇨🇦
@Jim_Rothman @aravind_233 I genuinely can't believe biotechs like $ALLR who can confidentially see the results of their ongoing trials are allowed to buy back shares in the open market... Great as an investor but am I crazy or should this be illegal lol
English
4
0
3
1.2K
micke-mai
micke-mai@stocklllovers6·
$IBRX what happened to the days of 300% jumps when cancer breakthroughs were approved and positive? This market where everything is controlled by hedge funds and market makers is ridiculous! Retail have been suppressed and choked since the squeezes of 2021, they won’t let anything run except for their ponzi schemes that the SEC ignore!
English
7
6
99
12.7K
Dr. Pat Soon-Shiong
Dr. Pat Soon-Shiong@DrPatrick·
It’s been quite a day. News coming soon re our sBLA response from FDA. Stay tuned.
English
95
137
1.1K
127.9K
Loud Outside
Loud Outside@LoudOutside·
Dude shows off his tattoo dedicated to chasing the bag 💰
Loud Outside tweet media
English
141
11
188
18.1K
Jordan Schmaltz
Jordan Schmaltz@J_Swish24·
Top-11 defensemen in the NHL: #1 Cale Makar #2 Quinn Hughes #3 Zach Werenski #4 Lane Hutson #5 Rasmus Dahlin #6 Chuck McAvoy #7 Brock Faber #8 Jake Sanderson #9 Matthew Schaefer #10 Miro Heiskanen #11 Evan Bouchard -People’s
Deutsch
643
26
2.1K
554.4K
Aj
Aj@Come1y·
Possible new species. They are referred to as “Homo Slackass-Erectus” created by natural genetic evolution through constant spineless posturing and spasmatic upper limb gestures, which nes research showing to cause a shorter legs and an inability to ambulate other than in an awkward shuffling gait…😂😂😂😂
Aj tweet media
GIF
English
16
20
266
13K
Sofia
Sofia@Sofia50020Sofia·
White men, what’s stopping you from dressing like this?
Sofia tweet media
English
17.9K
1.3K
6.9K
5.1M
Oncology Tube
Oncology Tube@oncologytube·
🧬 Is Alisertib the New Standard for Overcoming Resistance in KRAS G12C-Mutant NSCLC? 👉VIDEO: oncologytube.com/alisertib-kras… Recent data presents alisertib (elisrasib) as a potent option for both G12C-naive and refractory NSCLC patients. 🚀 Key Clinical Data: ✅ 52.9% ORR in treatment-naive patients ✅ 84% Disease Control Rate in refractory cases ✅ 15.6m Median Duration of Response for refractory patients @AACR @OncoAlert @RenoHemonc @EladSharonMD @chulkimMD @Stefani19753108 @YuZhu4 @zpyeung @TomPrt @yakkusoooooo @Molly20186 @AMRANEKarim6 @join_kana @cancerassassin1 @fireflyann @ortizaimed @Innov_Medicine @The_InnovationJ @AbiSivaMD @Davdwlkerson @YoichiKoyamaMD @KRASKickers @mybarra @ChadMoo47772206 @hirokane05 @FuturePH_Scott @gcai1978 @myfight4cancer @OncoUgi @FlyFan7 @AshleyWeiMD @15Jfco @goecp1 @oncobalaji @alejandroleonMD @everest_bio @TheAndreaSantos @drrifu @SheydaDoc @Wasim1846 #OncTwitter #LungCancer #NSCLC #KRAS #MedicalNews
Oncology Tube tweet media
English
4
4
1
632
Oncology Tube
Oncology Tube@oncologytube·
WATCH: New Data on Alisertib (elisrasib) in KRAS G12C-mutant NSCLC 🫁🧬 👉 oncologytube.com/alisertib-kras… ⚡ Rapid & potent target engagement 📈 Encouraging ORR + durable responses ✅ Favorable safety & tolerability profile Promising efficacy in heavily pretreated patients — including those with acquired resistance to prior G12C inhibitors 💪 @AACR @OncoAlert @RenoHemonc @EladSharonMD @chulkimMD @Stefani19753108 @YuZhu4 @zpyeung @TomPrt @yakkusoooooo @Molly20186 @AMRANEKarim6 @join_kana @cancerassassin1 @fireflyann @ortizaimed @Innov_Medicine @The_InnovationJ @AbiSivaMD @Davdwlkerson @YoichiKoyamaMD @KRASKickers @mybarra @ChadMoo47772206 @hirokane05 @FuturePH_Scott @gcai1978 @myfight4cancer @OncoUgi @FlyFan7 @AshleyWeiMD @15Jfco @goecp1 @oncobalaji @alejandroleonMD @everest_bio @TheAndreaSantos @drrifu @SheydaDoc @Wasim1846 #KRAS #NSCLC #LungCancer #PrecisionOncology #AACR2026 #TargetedTherapy
GIF
English
8
5
7
703
Robert Goulet
Robert Goulet@Dadbod4evah·
Decent volume first hour $crbu
English
0
0
3
219
The Random Guy
The Random Guy@RandomTheGuy_·
Nowadays people are built different 😱
English
13
3
44
5.5K
Tokyo
Tokyo@otokyo__·
Give him a rap name
Tokyo tweet media
English
894
18
179
29.5K